JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 27 No. 8 1321-1326
© 1986 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yen, C.-K.
Right arrow Articles by Lamb, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yen, C.-K.
Right arrow Articles by Lamb, J.

Portasystemic Shunt Fraction Quantification with Colonic Iodine-123 Iodoamphetamine

C.-K. Yen, M. Pollycove, R. Crass, T. H. Lin, R. Baldwin and J. Lamb

Departments of Nuclear Medicine and Surgery, San Francisco General Hospital Medical Center and University of California, San Francisco
Department of Nuclear Medicine, Presbyterian Hospital of San Francisco
Medi-Physics, Inc., Richmond, California

Correspondence: For reprints contact: Chi-Kwan Yen, MD, Dept. of Nuclear Medicine, Bldg. 100, San Francisco General Hospital Medical Center, 1001 Potrero Ave., San Francisco, CA 94110.

ABSTRACT

Portasystemic shunting was quantified in dogs with [123I]iodoamphetamine (IMP) administered transrectally into the colon and monitored externally with a gamma camera. IMP was absorbed rapidly and unchanged from the colon. After direct injection into the portal vein, IMP was almost completely extracted by the liver on the first pass, and the washout half-life was ~60 min. Based on these kinetic data, computer simulation of this biologic system was carried out. Errors associated with simplified models are calculated. The simplest model with insignificant error, which assumed that the tracer behaved like microspheres, was used to quantitate portasystemic shunt fraction in animals with surgically created shunts. Results were compared with the standard of 99mTc-labeled macroaggregated albumin infused into a branch of inferior mesenteric vein. For shunt fractions ranging from 0 to 100%, an excellent correlation was seen, indicating that this approach is potentially a simple, noninvasive method of portasystemic shunt fraction quantification.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1986 by the Society of Nuclear Medicine.